Daily non-political popular news in brief.

ACE inhibitors help preserve kidney function in IgA nephropathy

For young patients with the kidney disease IgA nephropathy, early treatment with angiotensin-converting enzyme inhibitors can reduce the long-term risk of irreversible kidney damage, suggests a study in the June Journal of the American Society of Nephrology.

Read more »

Keywords: ace, inhibitors, preserve, kidney, function, iga, nephropathy, inhibitor

« Previous | Next »

Similar news on "ACE inhibitors help preserve kidney function in IgA nephropathy":

1. New imaging technique holds promise to allow cancer surgeons to save more of the kidney
   06-05-2007 · EurekAlert!
   A new way to provide clear images of cancerous tumors in the kidney during surgery promises to help physicians preserve as much kidney function as possible while still removing all the malignant tissue -- a significant advance as doctors discover that saving as much healthy kidney tissue as possible is crucial for the future health of cancer patients.
   Similar news · Read more »
   
2. Perindopril for improving physical function in elderly people
   10-08-2007 · EurekAlert!
   Among those aged 65 and older, the ACE inhibitor perindopril significantly improved exercise capacity and maintained health-related quality of life compared with placebo.
   Similar news · Read more »
   
3. Glowing dye improves cancer removal in kidney
   06-05-2007 · EurekAlert!
   A new way to provide clear images of cancerous tumors in the kidney during surgery promises to help physicians preserve as much kidney function as possible while still removing all the malignant tissue -- a significant advance as doctors discover that saving as much healthy kidney tissue as possible is crucial for the future health of cancer patients.
   Similar news · Read more »
   
4. Combination therapy stops loss of kidney function in rare genetic disease
   07-25-2007 · EurekAlert!
   A combination of two types of blood pressure-lowering drugs -- an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, Mass.) -- is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
   Similar news · Read more »
   
5. Fosrenol does not further impact cognitive function deterioration in CKD Stage 5 patients
   10-18-2006 · EurekAlert!
   Newly published data from a large, two-year trial in the November Kidney International report on the effects of chronic kidney disease on cognitive function in CKD Stage 5 patients with hyperphosphatemia (high serum phosphorus levels in the blood), treated with phosphate binder therapy. This study is particularly relevant, as there is evidence that individuals with reduced renal function experience a significantly greater decline in cognitive function compared to those with normal renal function.
   Similar news · Read more »
   
6. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
   12-07-2006 · EurekAlert!
   Common blood pressure medications might help block the spread of pancreatic cancer, researchers have found. The scientists showed in laboratory studies that two types of pressure-lowering drugs -- ACE inhibitors and AT1R blockers -- may help reduce the development of tumor-feeding blood vessels, a process called angiogenesis. Such drugs, they say, may become part of a novel strategy to control the growth and spread of cancer.
   Similar news · Read more »
   
7. First step in developing heart hormone-based pill to control high blood pressure
   03-27-2007 · EurekAlert!
   In an era of increasing death and illness from heart and blood vessel disease -- which also can impair kidney function -- Mayo Clinic researchers have designed two promising new cardiovascular treatment approaches.
   Similar news · Read more »
   
8. Angioplasty procedure has potential to damage kidneys, research shows
   06-29-2007 · EurekAlert!
   The most common procedure for clearing blocked kidney arteries can also release thousands of tiny particles into the bloodstream that can impair kidney function, according to researchers from Wake Forest University Baptist Medical Center and colleagues.
   Similar news · Read more »
   
9. Study finds differences between blood pressure medicines and newly-diagnosed diabetes
   01-19-2007 · EurekAlert!
   Researchers at Rush University Medical Center analyzed the data from 22 randomized clinical trials, and have found significant differences between antihypertensive drugs. ACE-inhibitors and the newer angiotensin receptor blockers, or ARBs prevent people from getting diabetes, and the older diuretics or beta-blockers, increase the chance that a person becomes diabetic, compared to either placebo (inactive sugar-pills) or calcium channel blockers according to a study published in the January 20, 2007 issue of the Lancet.
   Similar news · Read more »
   
10. Discovery of an HIV inhibitor in human blood points to new drug class
    04-19-2007 · EurekAlert!
    A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
    Similar news · Read more »